Suppr超能文献

局部晚期乳腺癌分子亚型与 CA15-3 水平的相关性。

Association between molecular subtype of local advanced breast cancer with Ca 15-3 level.

机构信息

Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, Indonesia.

Division of Oncology Surgery, Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, Indonesia.

出版信息

Breast Dis. 2021;40(S1):S119-S122. doi: 10.3233/BD-219018.

Abstract

BACKGROUND

Neoplasm is an abnormal mass of tissue that grows excessively and not coordinated with normal tissue growth and continues to do so even though the stimulation that triggered the change has stopped. Breast cancer can be known by using tumor marker, which has been used is mucin-like glycoprotein Carcinoma Antigen (CA 15-3) which is a tumor marker that is specific to breast cancer.

METHOD

This study is a cross-sectional study to determine the association between molecular subtypes of locally advanced breast cancer with CA 15-3 level at Abdul Wahab Sjahranie Samarinda Hospital. The population in this study were all breast cancer patients that were confirmed by histopathological examination.

RESULTS

A total of 75 patients were included for this study, 29 patients (38.7%) known as Overexpression HER2, 18 patients (24.0%) were Luminal B with HER2 (+), 11 patients (14.7%) were Luminal B with HER2 (-), 11 patients (14.7%) were Basal-like/TNBC, and 6 patients (8,0%) were Luminal A. From the ANOVA test, the value of p = 0.045 (p < 0.05) means there was an association between Ca 15-3 level and molecular subtypes in patients with locally advanced breast cancer at the Abdul Wahab Sjahranie Hospital in Samarinda 2017. In this study Ca 15-3 levels were obtained on average for Luminal A 16.98 U/mL, Luminal B with HER2 (-) 42.41 U/mL, Luminal B with HER2 (+) 73.75 U/mL, Overexpression HER2 47.73 U/mL, and Basal Like /TNBC 63.50 U/mL.

CONCLUSION

Statistically, it was found that there was an association between Ca 15-3 levels and molecular subtypes in patients with locally advanced breast cancer at the Abdul Wahab Sjahranie Hospital in Samarinda 2017.

摘要

背景

肿瘤是一种组织的异常肿块,其过度生长且与正常组织生长不协调,即使触发这种变化的刺激已经停止,它仍会继续生长。乳腺癌可以通过使用肿瘤标志物来识别,已经使用的是黏蛋白样糖蛋白癌抗原(CA 15-3),这是一种特异性针对乳腺癌的肿瘤标志物。

方法

本研究是一项横断面研究,旨在确定阿卜杜勒·瓦哈卜·沙赫兰尼 Samarinda 医院局部晚期乳腺癌的分子亚型与 CA 15-3 水平之间的关联。本研究的人群为所有经组织病理学检查证实为乳腺癌的患者。

结果

本研究共纳入 75 例患者,其中 29 例(38.7%)为 HER2 过表达,18 例(24.0%)为 Luminal B 型伴 HER2(+),11 例(14.7%)为 Luminal B 型伴 HER2(-),11 例(14.7%)为基底样/TNBC 型,6 例(8.0%)为 Luminal A 型。通过方差分析,p 值=0.045(p<0.05),这意味着阿卜杜勒·瓦哈卜·沙赫兰尼 Samarinda 医院 2017 年局部晚期乳腺癌患者的 Ca 15-3 水平与分子亚型之间存在关联。在这项研究中,Luminal A 型患者的平均 Ca 15-3 水平为 16.98 U/mL,Luminal B 型伴 HER2(-)患者为 42.41 U/mL,Luminal B 型伴 HER2(+)患者为 73.75 U/mL,HER2 过表达患者为 47.73 U/mL,基底样/TNBC 患者为 63.50 U/mL。

结论

统计结果表明,阿卜杜勒·瓦哈卜·沙赫兰尼 Samarinda 医院 2017 年局部晚期乳腺癌患者的 Ca 15-3 水平与分子亚型之间存在关联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验